nach oben

Erschienen in:

22.02.2021 | Original Article

Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats

verfasst von: Josiane Budni, Arleide Braga Brandão, Sabrina da Silva, Michelle Lima Garcez, Francielle Mina, Tatiani Bellettini-Santos, Gabriel Casagrande Zabot, Eduarda Behenck Medeiros, Giselli Scaini, Jade de Oliveira, Emílio Luiz Streck, João Quevedo

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

D-galactose (D-gal) is a carbohydrate widely distributed in regular diets. However, D-gal administration in rodents is associated with behavioral and neurochemical alterations similar to features observed in aging. In this regard, this study aimed to investigate the effects of D-gal exposure, in different periods, in rats’ brain regions’ activities of creatine kinase (CK) and tricarboxylic acid (TCA) cycle enzymes. Male adult Wistar rats received D-gal (100 mg/kg, gavage) for 1, 2, 4, 6 or 8 weeks. CK and TCA enzymes’ activities were evaluated in rats’ prefrontal cortex and hippocampus. In general, the results showed an increase in citrate synthase (CS) and succinate dehydrogenase (SDH) activities in animals treated with D-gal compared to the control group in the prefrontal cortex and hippocampus. Also, in the fourth week, the malate dehydrogenase (MD) activity increased in the hippocampus of rats that received D-gal compared to control rats. In addition, we observed an increase in the CK activity in the prefrontal cortex and hippocampus in the first and eighth weeks of treatment in the D-gal group compared to the control group. D-gal administration orally administered modulated TCA cycle enzymes and CK activities in the prefrontal cortex and hippocampus, which were also observed in aging and neurodegenerative diseases. However, more studies using experimental models are necessary to understand better the impact and contribution of these brain metabolic abnormalities associated with D-gal consumption for aging.

Akhter F, Chen D, Akhter A, Yan SF, ShiDu Yan S (2020) Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress. Free Radic Biol Med 22:S0891-5849(20)31684-1. https://doi.org/10.1016/j.freeradbiomed.2020.12.021

Ali A, Shah SA, Zaman N et al (2021) Vitamin D exerts neuroprotection via SIRT1/nrf-2/ NF-kB signaling pathways against D-galactose-induced memory impairment in adult mice. Neurochem Int 142:104893. https://doi.org/10.1016/j.neuint.2020.104893CrossRefPubMed

Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes. 61(6):1315–22. https://doi.org/10.2337/db11-1300CrossRefPubMedPubMedCentral

Bénit P, Letouzé E, Rak M et al (2014) Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling. Biochim Biophys Acta 1837(8):1330–1337. https://doi.org/10.1016/j.bbabio.2014.03.013CrossRefPubMed

Bonilla E, Tanji K, Hirano M et al (1999) Mitochondrial involvement in Alzheimer’s disease. Biochim Biophys Acta 1410(2):171–182. https://doi.org/10.1016/s0005-2728(98)00165-0CrossRefPubMed

Bubber P, Haroutunian V, Fisch G et al (2005) Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57(5):695–703. https://doi.org/10.1002/ana.20474CrossRefPubMed

Budni J, Pacheco R, da Silva S et al (2016) Oral administration of d-galactose induces cognitive impairments and oxidative damage in rats. Behav Brain Res 302:35–43. https://doi.org/10.1016/j.bbr.2015.12.041CrossRefPubMed

Budni J, Garcez ML, Mina F et al (2017) The oral administration of D-galactose induces abnormalities within the mitochondrial respiratory chain in the brain of rats. Metab Brain Dis 32(3):811–817. https://doi.org/10.1007/s11011-017-9972-9CrossRefPubMed

Bürklen TS, Schlattner U, Homayouni R et al (2006) The creatine kinase/creatine connection to Alzheimer’s disease: CK-inactivation, APP-CK complexes and focal creatine deposits. J Biomed Biotechnol 2006(3):35936. https://doi.org/10.1155/JBB/2006/35936CrossRefPubMedPubMedCentral

Cenini G, Lloret A, Cascella R (2019) Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid Med Cell Longev 2019:2105607. https://doi.org/10.1155/2019/2105607

Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1–29. https://doi.org/10.1016/j.freeradbiomed.2013.03.018CrossRefPubMed

Chen B, Zhong Y, Peng W et al (2010) Age-related changes in the central auditory system: comparison of D-galactose-induced aging rats and naturally aging rats. Brain Res 1344:43–53. https://doi.org/10.1016/j.brainres.2010.04.082CrossRefPubMed

Chen C, Huang L, Nong Z, Li Y, Chen W, Huang J, Pan X, Wu G, Lin Y (2017) Hyperbaric oxygen prevents cognitive impairments in mice induced by d-galactose by improving cholinergic and anti-apoptotic functions. Neurochem Res 42(4):1240–1253. https://doi.org/10.1007/s11064-016-2166-8CrossRefPubMed

Chen P, Chen F, Zhou B (2018) Antioxidative, anti-inflammatory and anti-apoptotic effects of ellagic acid in liver and brain of rats treated by D-galactose. Sci Rep 8(1):1465. https://doi.org/10.1038/s41598-018-19732-0CrossRefPubMedPubMedCentral

Chou JL, Shenoy DV, Thomas N et al (2011) Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer’s disease. J Proteomics 74(4):466–479. https://doi.org/10.1016/j.jprot.2010.12.012CrossRefPubMed

Cohn RM, Segal S (1973) Galactose metabolism and its regulation. Metabolism 22(4):627–642. https://doi.org/10.1016/0026-0495(73)90078-4CrossRefPubMed

Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J et al (2006) Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 84:647–654. https://doi.org/10.1002/jnr.20899CrossRefPubMed

Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S et al (2011) Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 27(1):3–20. https://doi.org/10.1016/j.nut.2010.07.021CrossRefPubMed

Daenzer JM, Fridovich-Keil JL (2017) Drosophila melanogaster Models of Galactosemia. Curr Top Dev Biol 121:377–395. https://doi.org/10.1016/bs.ctdb.2016.07.009CrossRefPubMed

Dong Y, Brewer GJ (2019) Global metabolic shifts in age and Alzheimer’s disease mouse brains pivot at NAD+/NADH redox sites. J Alzheimers Dis 71(1):119–140. https://doi.org/10.3233/JAD-190408CrossRefPubMedPubMedCentral

Feng Z, Hanson RW, Berger NA, Trubitsyn A (2016) Reprogramming of energy metabolism as a driver of aging. Oncotarget 7(13):15410–15420. https://doi.org/10.18632/oncotarget.7645CrossRefPubMedPubMedCentral

Fischer JC, Ruitenbeek W, Berden JA et al (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153(1):23–36. https://doi.org/10.1016/0009-8981(85)90135-4CrossRefPubMed

Garcez ML, de Carvalho CA, Mina F, Bellettini-Santos T, Schiavo GL, da Silva S, Campos ACBF, Varela RB, Valvassori SS, Damiani AP, Longaretti LM, de Andrade VM, Budni J (2018) Sodium butyrate improves memory and modulates the activity of histone deacetylases in aged rats after the administration of d-galactose. Exp Gerontol 113:209–217. https://doi.org/10.1016/j.exger.2018.10.005CrossRefPubMed

Garcez ML, Cassoma RCS, Mina F, Bellettini-Santos T, da Luz AP, Schiavo GL, Medeiros EB, Campos ACBF, da Silva S, Rempel LCT, Steckert AV, Barichello T, Budni J (2021) Folic acid prevents habituation memory impairment and oxidative stress in an aging model induced by D-galactose. Metab Brain Dis 36(2):213–224. https://doi.org/10.1007/s11011-020-00647-7CrossRefPubMed

Gibson GE, Karuppagounder SS, Shi Q (2008) Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer’s disease. Ann N Y Acad Sci 1147:221–232. https://doi.org/10.1196/annals.1427.038CrossRefPubMedPubMedCentral

Guo C, Sun L, Chen X et al (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003–2014. https://doi.org/10.3969/j.issn.1673-5374.2013.21.009CrossRefPubMedPubMedCentral

Guo X, Park JE, Gallart-Palau X, Sze SK (2020) Oxidative damage to the TCA cycle enzyme MDH1 dysregulates bioenergetic enzymatic activity in the aged murine brain. J Proteome Res 19(4):1706–1717. https://doi.org/10.1021/acs.jproteome.9b00861CrossRefPubMed

Haas RH (2019) Mitochondrial dysfunction in aging and diseases of aging. Biology (Basel) 8(2):48. https://doi.org/10.3390/biology8020048CrossRef

Haider S, Liaquat L, Ahmad S et al (2020) Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress. PLoS One 15(1):e0227631. https://doi.org/10.1371/journal.pone.0227631CrossRefPubMedPubMedCentral

Holtzman DM, Morris JC, Goate AM (2011) Alzheimer’s disease: the challenge of the second century. Sci Transl Med 3(77):77sr1.https://doi.org/10.1126/scitranslmed.3002369CrossRefPubMedPubMedCentral

Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15(10):565–581. https://doi.org/10.1038/s41582-019-0244-7CrossRefPubMed

Hua X, Lei M, Zhang Y et al (2007) Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer’s disease. Life Sci 80:1897–1905. https://doi.org/10.1016/j.lfs.2007.02.030CrossRefPubMed

Hughes BP (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7:597–603. https://doi.org/10.1016/0009-8981(62)90137-7

Kenawy S, Hegazy R, Hassan A et al (2017) Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin. PLoS One 12(8):e0183565. https://doi.org/10.1371/journal.pone.0183565CrossRefPubMedPubMedCentral

Khatri N, Man HY (2013) Synaptic activity and bioenergy homeostasis: implications in brain trauma and neurodegenerative diseases. Front Neurol 4:199. https://doi.org/10.3389/fneur.2013.00199CrossRefPubMedPubMedCentral

Koubaa M, Cocuron JC, Thomasset B et al (2013) Highlighting the tricarboxylic acid cycle: liquid and gas chromatography-mass spectrometry analyses of (13)C-labeled organic acids. Anal Biochem 436(2):151–159. https://doi.org/10.1016/j.ab.2013.01.027CrossRefPubMed

Kumar A, Prakash A, Dogra S (2010) Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem Toxicol 48(2):626–632. https://doi.org/10.1016/j.fct.2009.11.043CrossRefPubMed

Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, Hanson RW, Kalhan SC, Ryals JA, Milburn MV (2008) Analysis of the adult human plasma metabolome. Pharmacogenomics 9(4):383-97. https://doi.org/10.2217/14622416.9.4.383

Liu J, Chen D, Wang Z et al (2019) Protective effect of walnut on d-galactose-induced aging mouse model. Food Sci Nutr 7(3):969–976. https://doi.org/10.1002/fsn3.907CrossRefPubMedPubMedCentral

Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275CrossRefPubMed

Lu J, Zheng YL, Wu DM et al (2007) Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochem Pharmacol 74:1078–1090. https://doi.org/10.1016/j.bcp.2007.07.007CrossRefPubMed

Lynn BC, Wang J, Markesbery WR et al (2010) Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer’s disease. J Alzheimers Dis 19(1):325–339. https://doi.org/10.3233/JAD-2010-1254CrossRefPubMedPubMedCentral

Manczak M, Park BS, Jung Y et al (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 5(2):147–162. https://doi.org/10.1385/NMM:5:2:147CrossRefPubMed

Moldogazieva NT, Mokhosoev IM, Mel'nikova TI et al (2019) Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases. Oxid Med Cell Longev 2019:3085756. https://doi.org/10.1155/2019/3085756

Mosconi L (2013) Glucose metabolism in normal aging and Alzheimer’s disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging 1(4). https://doi.org/10.1007/s40336-013-0026-y

Nam SM, Seo M, Seo JS et al (2019) Ascorbic acid mitigates D-galactose-induced brain aging by increasing hippocampal neurogenesis and improving memory function. Nutrients 11(1). https://doi.org/10.3390/nu11010176

Owen OE, Kalhan SC, Hanson RW (2002) The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 277(34):30409–30412. https://doi.org/10.1074/jbc.R200006200CrossRefPubMed

Palaniappan AR, Dai A (2007) Mitochondrial ageing and the beneficial role of alpha-lipoic acid. Neurochem Res 32(9):1552–1558. https://doi.org/10.1007/s11064-007-9355-4CrossRefPubMed

Pollack M, Leeuwenburgh C (2001) Apoptosis and aging: role of the mitochondria. J Gerontol A Biol Sci Med Sci 56(11):B475–B482. https://doi.org/10.1093/gerona/56.11.b475CrossRefPubMed

Reddy PH, McWeeney S, Park BS et al (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer’s disease. Hum Mol Genet 13(12):1225–1240. https://doi.org/10.1093/hmg/ddh140CrossRefPubMed

Rustin P, Munnich A, Rötig A (2002) Succinate dehydrogenase and human diseases: new insights into a well-known enzyme. Eur J Hum Genet 10(5):289–291. https://doi.org/10.1038/sj.ejhg.5200793CrossRefPubMed

Sadigh-Eteghad S, Majdi A, McCann SK et al (2017) D-galactose-induced brain ageing model: A systematic review and meta-analysis on cognitive outcomes and oxidative stress indices. PLoS One 12(8):e0184122 https://doi.org/10.1371/journal.pone.0184122CrossRefPubMedPubMedCentral

Saks V, Kaambre T, Guzun R et al (2007) The creatine kinase phosphotransfer network: thermodynamic and kinetic considerations, the impact of the mitochondrial outer membrane and modelling approaches. Subcell Biochem 46:27–65. https://doi.org/10.1007/978-1-4020-6486-9_3

Salminen A, Kauppinen A, Hiltunen M, Kaarniranta K (2014) Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process. Ageing Res Rev 16:45–65. https://doi.org/10.1016/j.arr.2014.05.004CrossRefPubMed

Schlattner U, Tokarska-Schlattner M, Wallimann T (2006) Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 1762(2):164–180. https://doi.org/10.1016/j.bbadis.2005.09.004CrossRefPubMed

Selvaraji S, Poh L, Natarajan V et al (2019) Negative conditioning of mitochondrial dysfunction in age-related neurodegenerative diseases. Cond Med 2(1):30–39PubMedPubMedCentral

Shepherd D, Garland PB (1969) The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 114(3):597–610. https://doi.org/10.1042/bj1140597CrossRefPubMedPubMedCentral

Shi Q, Gibson GE (2011) Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a. J Neurochem 118(3):440–448. https://doi.org/10.1111/j.1471-4159.2011.07333.xCrossRefPubMedPubMedCentral

Song X, Bao M, Li D, Li YM (1999) Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev 108(3):239–251. https://doi.org/10.1016/s0047-6374(99)00022-6CrossRefPubMed

Sonnay S, Gruetter R, Duarte JMN (2017) How energy metabolism supports cerebral function: insights from 13 C magnetic resonance studies in vivo. Front Neurosci 11:288. (eCollection 2017) https://doi.org/10.3389/fnins.2017.00288CrossRefPubMedPubMedCentral

Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80:1107–1213. https://doi.org/10.1152/physrev.2000.80.3.1107CrossRefPubMed

Xian YF, Lin ZX, Zhao M et al (2011) Uncaria rhynchophylla ameliorates cognitive deficits induced by D-galactose in mice. Planta Med 77(18):1977–1983. https://doi.org/10.1055/s-0031-1280125CrossRefPubMed

Xiao F, Li XG, Zhang XY et al (2011) Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain. Neurosci Bull 27(3):143–155. https://doi.org/10.1007/s12264-011-1028-2CrossRefPubMedPubMedCentral

Yan X, Hu Y, Wang B, Wang S, Zhang X (2020) Metabolic dysregulation contributes to the progression of Alzheimer’s disease. Front Neurosci 14:530219. https://doi.org/10.3389/fnins.2020.530219CrossRefPubMedPubMedCentral

Yin F, Sancheti H, Liu Z, Cadenas E (2016) Mitochondrial function in ageing: coordination with signalling and transcriptional pathways. J Physiol 594(8):2025–2042. https://doi.org/10.1113/JP270541CrossRefPubMed

Zhou XQ, Yao ZW, Peng Y et al (2018) PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3β/Akt signaling pathway in mouse. Sci Rep 8(1):8894. https://doi.org/10.1038/s41598-018-26962-9CrossRefPubMedPubMedCentral

Titel: Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats
verfasst von: Josiane Budni
Arleide Braga Brandão
Sabrina da Silva
Michelle Lima Garcez
Francielle Mina
Tatiani Bellettini-Santos
Gabriel Casagrande Zabot
Eduarda Behenck Medeiros
Giselli Scaini
Jade de Oliveira
Emílio Luiz Streck
João Quevedo
Publikationsdatum: 22.02.2021
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 5/2021
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-021-00682-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Oral administration of D-galactose increases brain tricarboxylic acid cycle enzymes activities in Wistar rats

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations

In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy

Methods used for the measurement of blood-brain barrier integrity

Hippocampal cellular changes in androgen deprived insulin resistant rats

Perfusion microvessel density in the cerebral cortex of septic rats is negatively correlated with endothelial microparticles in circulating plasma

Association of lncRNA with regulatory molecular factors in brain and their role in the pathophysiology of schizophrenia

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie